ARCHIVES

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds

March 28, 2003